Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 29 hits in this display
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
Ki: 1.10nMAssay Description:Compound was tested for its binding affinity for alpha-1 adrenergic receptor site by displacement of [3H]clonidine at 10e-6 M concentrationMore data for this Ligand-Target Pair
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
Ki: 2.20nMAssay Description:Compound was tested for its binding affinity for alpha-1 adrenergic receptor site by displacement of [3H]clonidine at 10e-6 M concentrationMore data for this Ligand-Target Pair
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
Ki: 2.20nMAssay Description:Compound was tested for its binding affinity for alpha-1 adrenergic receptor site by displacement of [3H]clonidine at 10e-6 M concentrationMore data for this Ligand-Target Pair
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
Heparanase(Homo sapiens (Human))Beta Therapeutics
US Patent
BDBM611698(US11718609, Compound BT2013)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)
BDBM86731(CAS_74191-85-8 | Doxazosin | UK 33,274)